Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Phyllis Jean Kanki, D.Sc., D.V.M.

TitleProfessor of Immunology and Infectious Diseases
InstitutionHarvard School of Public Health
DepartmentImmunology and Infectious Diseases
AddressHarvard School of Public Health
Immunology & Infect Disease, FXB 405B
651 Huntington Ave
Boston MA 02115
Phone617/432-1267
Other Positions
InstitutionHarvard School of Public Health
DepartmentImmunology and Infectious Diseases


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ladep NG, Agaba PA, Agbaji O, Muazu A, Ugoagwu P, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J, Kanki P. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World J Gastroenterol. 2013 Mar 14; 19(10):1602-10.
    View in: PubMed
  2. Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. J Acquir Immune Defic Syndr. 2013 Feb 1; 62(2):204-7.
    View in: PubMed
  3. Kanki P, Kakkattil P, Simao M. Scaling up HIV treatment and prevention through national responses and innovative leadership. J Acquir Immune Defic Syndr. 2012 Aug 1; 60 Suppl 2:S27-30.
    View in: PubMed
  4. Dinic L, Akande P, Idigbe EO, Ani A, Onwujekwe D, Agbaji O, Akanbi M, Nwosu R, Adeniyi B, Wahab M, Lekuk C, Kunle-Ope C, Nwokoye N, Kanki P. Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria. J Clin Microbiol. 2012 Sep; 50(9):2905-9.
    View in: PubMed
  5. Tang MW, Kanki PJ, Shafer RW. A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy. Clin Infect Dis. 2012 Mar; 54(6):862-75.
    View in: PubMed
  6. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011 Dec; 53(12):1283-90.
    View in: PubMed
  7. Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, Murphy R, Kanki P. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. J Infect Dev Ctries. 2011 May; 5(5):377-82.
    View in: PubMed
  8. Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to infected children in a Nigerian HIV Care Programme. AIDS Care. 2011 Sep; 23(9):1053-8.
    View in: PubMed
  9. Agbaji OO, Agaba PA, Idoko JA, Taiwo B, Murphy R, Kanki P, Ekong E. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians. West Afr J Med. 2011 May-Jun; 30(3):164-8.
    View in: PubMed
  10. Brown BJ, Oladokun RE, Odaibo GN, Olaleye DO, Osinusi K, Kanki P. Clinical and Immunological Profile of Pediatric HIV Infection in Ibadan, Nigeria. J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb; 10(1):49-53.
    View in: PubMed
  11. Chaplin B, Eisen G, Idoko J, Onwujekwe D, Idigbe E, Adewole I, Gashau W, Meloni S, Sarr AD, Sankalé JL, Ekong E, Murphy RL, Kanki P. Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy. AIDS Res Hum Retroviruses. 2011 Jan; 27(1):71-80.
    View in: PubMed
  12. Akinyemi JO, Awolude OA, Adewole IF, Kanki PJ. Condom use among antiretroviral therapy patients in Ibadan, Nigeria. J Infect Dev Ctries. 2010 Aug; 4(8):495-502.
    View in: PubMed
  13. Oladokun RE, Awolude O, Brown BJ, Adesina O, Oladokun A, Roberts A, Odaibo G, Osinusi K, Olaleye D, Adewole IF, Kanki P. Service uptake and performance of the prevention of mother-to-child transmission (PMTCT) programme in Ibadan, Nigeria. Afr J Med Med Sci. 2010 Jun; 39(2):81-7.
    View in: PubMed
  14. Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Curr HIV Res. 2010 Apr; 8(3):194-8.
    View in: PubMed
  15. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis. 2009 Oct 15; 49(8):1268-73.
    View in: PubMed
  16. Hawkins CA, Chaplin B, Idoko J, Ekong E, Adewole I, Gashau W, Murphy RL, Kanki P. Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria. J Acquir Immune Defic Syndr. 2009 Oct 1; 52(2):228-34.
    View in: PubMed
  17. Strong CL, Lanchy JM, Dieng-Sarr A, Kanki PJ, Lodmell JS. A 5'UTR-spliced mRNA isoform is specialized for enhanced HIV-2 gag translation. J Mol Biol. 2009 Aug 14; 391(2):426-37.
    View in: PubMed
  18. Agaba PA, Sule HM, Ojoh RO, Hassan Z, Apena L, Mu'azu MA, Badung B, Agbaji OO, Idoko JA, Kanki P. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria. Int J STD AIDS. 2009 Jun; 20(6):410-3.
    View in: PubMed
  19. Ulenga NK, Sarr AD, Hamel D, Sankale JL, Mboup S, Kanki PJ. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. AIDS Res Hum Retroviruses. 2008 Oct; 24(10):1285-90.
    View in: PubMed
  20. Ojesina AI, Chaplin B, Sankalé JL, Murphy R, Idigbe E, Adewole I, Ekong E, Idoko J, Kanki PJ. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG. AIDS Res Hum Retroviruses. 2008 Sep; 24(9):1167-74.
    View in: PubMed
  21. Ulenga NK, Sarr AD, Thakore-Meloni S, Sankalé JL, Eisen G, Kanki PJ. Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F. J Infect Dis. 2008 Aug 15; 198(4):486-92.
    View in: PubMed
  22. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol. 2008 Apr-Jun; 7(2):152-6.
    View in: PubMed
  23. Ojesina AI, Mullins C, Imade G, Samuels J, Sankalé JL, Pam S, Sagay S, Idoko J, Kanki PJ. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria. AIDS Res Hum Retroviruses. 2007 Dec; 23(12):1587-92.
    View in: PubMed
  24. Idoko JA, Agbaji O, Agaba P, Akolo C, Inuwa B, Hassan Z, Akintunde L, Badung B, Muazu M, Danang M, Imade G, Sankale JL, Kanki P. Direct observation therapy-highly active antiretroviral therapy in a resource-limited setting: the use of community treatment support can be effective. Int J STD AIDS. 2007 Nov; 18(11):760-3.
    View in: PubMed
  25. Hamel DJ, Sankalé JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, Mboup S, Kanki PJ. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. AIDS Res Hum Retroviruses. 2007 Oct; 23(10):1189-96.
    View in: PubMed
  26. Sankalé JL, Langevin S, Odaibo G, Meloni ST, Ojesina AI, Olaleye D, Kanki P. The complexity of circulating HIV type 1 strains in Oyo state, Nigeria. AIDS Res Hum Retroviruses. 2007 Aug; 23(8):1020-5.
    View in: PubMed
  27. Ladep NG, Agbaji O, Agaba P, Badung P, Imade G, Sankalé J, Idoko J, Kanki P. Does immunological status affect the prevalence of Hepatitis C virus infection among HIV/AIDS patients? Niger J Med. 2007 Jul-Sep; 16(3):231-4.
    View in: PubMed
  28. Sierra B, Alegre R, Pérez AB, García G, Sturn-Ramirez K, Obasanjo O, Aguirre E, Alvarez M, Rodriguez-Roche R, Valdés L, Kanki P, Guzmán MG. HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol. 2007 Jun; 68(6):531-40.
    View in: PubMed
  29. MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J Virol. 2007 May; 81(10):5325-30.
    View in: PubMed
  30. Rodriguez SK, Sarr AD, MacNeil A, Thakore-Meloni S, Gueye-Ndiaye A, Traoré I, Dia MC, Mboup S, Kanki PJ. Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections. J Virol. 2007 May; 81(10):5331-8.
    View in: PubMed
  31. MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. J Infect Dis. 2007 Mar 1; 195(5):726-33.
    View in: PubMed
  32. Ojesina AI, Kanki PJ. HIV-1 subtype and reverse transcriptase genotype: role for geographical location and founder effects. PLoS Med. 2006 Dec; 3(12):e540.
    View in: PubMed
  33. Sagay AS, Musa J, Ekwempu CC, Imade GE, Babalola A, Daniyan G, Malu N, Idoko JA, Kanki P. Partner disclosure of HIV status among HIV positive mothers in Northern Nigeria. Afr J Med Med Sci. 2006 Dec; 35 Suppl:119-23.
    View in: PubMed
  34. Rodriguez SK, Sarr AD, Olorunnipa O, Popper SJ, Gueye-Ndiaye A, Traoré I, Dia MC, Mboup S, Kanki PJ. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection. J Infect Dis. 2006 Sep 15; 194(6):760-3.
    View in: PubMed
  35. Ojesina AI, Sankalé JL, Odaibo G, Langevin S, Meloni ST, Sarr AD, Olaleye D, Kanki PJ. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response. AIDS Res Hum Retroviruses. 2006 Aug; 22(8):770-9.
    View in: PubMed
  36. MacNeil A, Sankalé JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. J Virol. 2006 Aug; 80(15):7316-21.
    View in: PubMed
  37. Sankalé JL, Tong Q, Hadigan CM, Tan G, Grinspoon SK, Kanki PJ, Hotamisligil GS. Regulation of adiponectin in adipocytes upon exposure to HIV-1. HIV Med. 2006 May; 7(4):268-74.
    View in: PubMed
  38. Sagay AS, Musa J, Adewole AS, Imade GE, Ekwempu CC, Kapiga S, Sankale JL, Idoko J, Kanki P. Rapid HIV testing and counselling in labour in a northern Nigerian setting. Afr J Reprod Health. 2006 Apr; 10(1):76-80.
    View in: PubMed
  39. Hanson A, Sarr AD, Shea A, Jones N, Mboup S, Kanki P, Cao H. Distinct profile of T cell activation in HIV type 2 compared to HIV type 1 infection: differential mechanism for immunoprotection. AIDS Res Hum Retroviruses. 2005 Sep; 21(9):791-8.
    View in: PubMed
  40. Idigbe EO, Adewole TA, Eisen G, Kanki P, Odunukwe NN, Onwujekwe DI, Audu RA, Araoyinbo ID, Onyewuche JI, Salu OB, Adedoyin JA, Musa AZ. Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program. J Acquir Immune Defic Syndr. 2005 Sep 1; 40(1):65-9.
    View in: PubMed
  41. Sagay AS, Kapiga SH, Imade GE, Sankale JL, Idoko J, Kanki P. HIV infection among pregnant women in Nigeria. Int J Gynaecol Obstet. 2005 Jul; 90(1):61-7.
    View in: PubMed
  42. Aina O, Dadik J, Charurat M, Amangaman P, Gurumdi S, Mang E, Guyit R, Lar N, Datong P, Daniyam C, Kanki P, Abimiku A. Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol. 2005 Apr; 12(4):525-30.
    View in: PubMed
  43. Sarr AD, Eisen G, Guèye-Ndiaye A, Mullins C, Traoré I, Dia MC, Sankalé JL, Faye D, Mboup S, Kanki P. Viral dynamics of primary HIV-1 infection in Senegal, West Africa. J Infect Dis. 2005 May 1; 191(9):1460-7.
    View in: PubMed
  44. Imade GE, Badung B, Pam S, Agbaji O, Egah D, Sagay AS, Sankalé JL, Kapiga S, Idoko J, Kanki P. Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting. Clin Diagn Lab Immunol. 2005 Jan; 12(1):224-7.
    View in: PubMed
  45. Meloni ST, Kim B, Sankalé JL, Hamel DJ, Tovanabutra S, Mboup S, McCutchan FE, Kanki PJ. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. J Virol. 2004 Nov; 78(22):12438-45.
    View in: PubMed
  46. Meloni ST, Sankalé JL, Hamel DJ, Eisen G, Guéye-Ndiaye A, Mboup S, Kanki PJ. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. J Virol. 2004 Nov; 78(22):12455-61.
    View in: PubMed
  47. McCutchan FE, Sankale JL, M'Boup S, Kim B, Tovanabutra S, Hamel DJ, Brodine SK, Kanki PJ, Birx DL. HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res Hum Retroviruses. 2004 Aug; 20(8):819-26.
    View in: PubMed
  48. Shea A, Sarr DA, Jones N, Penning L, Eisen G, Gueye-Ndiaye A, Mboup S, Kanki P, Cao H. CCR5 receptor expression is down-regulated in HIV type 2 infection: implication for viral control and protection. AIDS Res Hum Retroviruses. 2004 Jun; 20(6):630-5.
    View in: PubMed
  49. Mullins C, Eisen G, Popper S, Dieng Sarr A, Sankale JL, Berger JJ, Wright SB, Chang HR, Coste G, Cooley TP, Rice P, Skolnik PR, Sullivan M, Kanki PJ. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clin Infect Dis. 2004 Jun 15; 38(12):1771-9.
    View in: PubMed
  50. Tong Q, Sankalé JL, Hadigan CM, Tan G, Rosenberg ES, Kanki PJ, Grinspoon SK, Hotamisligil GS. Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices. J Clin Endocrinol Metab. 2003 Apr; 88(4):1559-64.
    View in: PubMed
  51. Gilbert PB, McKeague IW, Eisen G, Mullins C, Guéye-NDiaye A, Mboup S, Kanki PJ. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal. Stat Med. 2003 Feb 28; 22(4):573-93.
    View in: PubMed
  52. Mani I, Gilbert P, Sankalé JL, Eisen G, Mboup S, Kanki PJ. Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection. J Virol. 2002 Nov; 76(21):10745-55.
    View in: PubMed
  53. Diouf K, Sarr AD, Eisen G, Popper S, Mboup S, Kanki P. Associations between MHC class I and susceptibility to HIV-2 disease progression. J Hum Virol. 2002 Jan-Feb; 5(1):1-7.
    View in: PubMed
  54. Dieye TN, Sow PS, Simonart T, Guèye-Ndiaye A, Popper SJ, Delforge ML, Dieye A, Sarr AD, Crusiaux A, Van Vooren JP, Devleeschouwer M, Kanki P, Mboup S, Diakhate L, Farber CM. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals. Vaccine. 2001 Dec 12; 20(5-6):905-13.
    View in: PubMed
  55. McKeague IW, Gilbert PB, Kanki PJ. Omnibus tests for comparison of competing risks with adjustment for covariate effects. Biometrics. 2001 Sep; 57(3):818-28.
    View in: PubMed
  56. Sarr AD, Lu Y, Sankalé JL, Eisen G, Popper S, Mboup S, Kanki PJ, Cao H. Robust HIV type 2 cellular immune response measured by a modified anthrax toxin-based enzyme-linked immunospot assay. AIDS Res Hum Retroviruses. 2001 Sep 1; 17(13):1257-64.
    View in: PubMed
  57. Cao H, Mani I, Vincent R, Mugerwa R, Mugyenyi P, Kanki P, Ellner J, Walker BD. Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda. J Infect Dis. 2000 Nov; 182(5):1350-6.
    View in: PubMed
  58. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, Mboup S, Kanki PJ. High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis. 2000 Aug; 182(2):467-73.
    View in: PubMed
  59. Kokkotou EG, Sankale JL, Mani I, Gueye-Ndiaye A, Schwartz D, Essex ME, Mboup S, Kanki PJ. In vitro correlates of HIV-2-mediated HIV-1 protection. Proc Natl Acad Sci U S A. 2000 Jun 6; 97(12):6797-802.
    View in: PubMed
  60. Sankalé JL, Hamel D, Woolsey A, Traoré T, Dia TC, Guèye-Ndiaye A, Essex M, Mboup T, Kanki P. Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997. J Hum Virol. 2000 May-Jun; 3(3):157-64.
    View in: PubMed
  61. Sarr AD, Sankalé JL, Hamel DJ, Travers KU, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Virology. 2000 Mar 15; 268(2):402-10.
    View in: PubMed
  62. Castillo RC, Arango-Jaramillo S, John R, Weinhold K, Kanki P, Carruth L, Schwartz DH. Resistance to human immunodeficiency virus type 1 in vitro as a surrogate of vaccine-induced protective immunity. J Infect Dis. 2000 Mar; 181(3):897-903.
    View in: PubMed
  63. Malone JD, Sheffield J, Tribble D, Lowe-Bey F, Cannon M, Slaughter-Allen M, Brown AE, Kanki PJ. Evaluation of three rapid/simple tests for detection of HIV-2 antibodies. J Acquir Immune Defic Syndr. 2000 Mar 1; 23(3):281-3.
    View in: PubMed
  64. Sarr AD, Sankalé JL, Guèye-Ndiaye A, Essex M, Mboup S, Kanki PJ. Genetic analysis of HIV type 2 in monotypic and dual HIV infections. AIDS Res Hum Retroviruses. 2000 Feb 10; 16(3):295-8.
    View in: PubMed
  65. Leonard L, Ndiaye I, Kapadia A, Eisen G, Diop O, Mboup S, Kanki P. HIV prevention among male clients of female sex workers in Kaolack, Senegal: results of a peer education program. AIDS Educ Prev. 2000 Feb; 12(1):21-37.
    View in: PubMed
  66. Popper SJ, Sarr AD, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol. 2000 Feb; 74(3):1554-7.
    View in: PubMed
  67. Sturm-Ramirez K, Brumblay H, Diop K, Guèye-Ndiaye A, Sankalé JL, Thior I, N'Doye I, Hsieh CC, Mboup S, Kanki PJ. Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa. J Clin Microbiol. 2000 Jan; 38(1):138-45.
    View in: PubMed
  68. Mani I, Cao H, Hom D, Johnson JL, Mugerwa RD, Travers KU, Caliendo AM, Walker BD, Kanki PJ. Plasma RNA viral load as measured by the branched DNA and nucleic acid sequence-based amplification assays of HIV-1 subtypes A and D in Uganda. J Acquir Immune Defic Syndr. 1999 Oct 1; 22(2):208-9.
    View in: PubMed
  69. Popper SJ, Sarr AD, Travers KU, Guèye-Ndiaye A, Mboup S, Essex ME, Kanki PJ. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis. 1999 Oct; 180(4):1116-21.
    View in: PubMed
  70. Plantier JC, Damond F, Lasky M, Sankalé JL, Apetrei C, Peeters M, Buzelay L, M'Boup S, Kanki P, Delaporte E, Simon F, Barin F. V3 serotyping of HIV-1 infection: correlation with genotyping and limitations. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):432-41.
    View in: PubMed
  71. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh Cc, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999 Jan; 179(1):68-73.
    View in: PubMed
  72. Sarr AD, Popper S, Thior I, Hamel DJ, Sankalé JL, Siby T, Marlink R, Essex M, Mboup S, Kanki P. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. J Hum Virol. 1999 Jan-Feb; 2(1):45-51.
    View in: PubMed
  73. Clark NM, Dieng Sarr A, Sankalé JL, Kanki PJ, Kazanjian P, Winfield R, Markovitz DM. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy. AIDS. 1998 Dec 24; 12(18):2506-7.
    View in: PubMed
  74. Sankalé JL, Mboup S, Essex ME, Kanki PJ. Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women. AIDS Res Hum Retroviruses. 1998 Nov 1; 14(16):1473-81.
    View in: PubMed
  75. Kokkotou E, Philippon V, Guèye-Ndiaye A, Mboup S, Wang WK, Essex M, Kanki P. Role of the CCR5 delta 32 allele in resistance to HIV-1 infection in west Africa. J Hum Virol. 1998 Nov-Dec; 1(7):469-74.
    View in: PubMed
  76. Popper SJ, Sankalé JL, Thior I, Siby T, Marlink RG, Mboup S, Essex M, Kanki PJ. Antibodies to the HIV type 2 core protein p26 and Vpx: association with disease progression. AIDS Res Hum Retroviruses. 1998 Sep 1; 14(13):1157-62.
    View in: PubMed
  77. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankalé JL, Marlink RG, Coll-Seck EM, Essex ME, Siby T, NDoye I, Mboup S, Kanki PJ. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS. 1998 Jan 22; 12(2):131-7.
    View in: PubMed
  78. Travers KU, Eisen GE, Marlink RG, Essex ME, Hsieh CC, Mboup S, Kanki PJ. Protection from HIV-1 infection by HIV-2. AIDS. 1998 Jan 22; 12(2):224-5.
    View in: PubMed
  79. Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J Virol. 1997 Nov; 71(11):8615-23.
    View in: PubMed
  80. Thior I, Diouf G, Diaw IK, Sarr AD, Hsieh CC, Ndoye I, Mboup S, Chen L, Essex M, Marlink R, Kanki P. Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal. Afr J Reprod Health. 1997 Sep; 1(2):26-35.
    View in: PubMed
  81. Kanki PJ, Peeters M, Guéye-Ndiaye A. Virology of HIV-1 and HIV-2: implications for Africa. AIDS. 1997; 11 Suppl B:S33-42.
    View in: PubMed
  82. Sankalé JL, De La Tour RS, Marlink RG, Scheib R, Mboup S, Essex ME, Kanki PJ. Distinct quasi-species in the blood and the brain of an HIV-2-infected individual. Virology. 1996 Dec 15; 226(2):418-23.
    View in: PubMed
  83. Kanki PJ, Eisen G, Travers KU, Marlink RG, Essex ME, Hsieh CC, Mboup S. Response: HIV-2 and Natural Protection Against HIV-1 Infection. Science. 1996 Jun 28; 272(5270):1959b-60b.
    View in: PubMed
  84. Erdman SE, Kanki PJ, Moore FM, Brown SA, Kawasaki TA, Mikule KW, Travers KU, Badylak SF, Fox JG. Clusters of lymphoma in ferrets. Cancer Invest. 1996; 14(3):225-30.
    View in: PubMed
  85. Sankalé JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses. 1995 May; 11(5):617-23.
    View in: PubMed
  86. Erdman SE, Reimann KA, Moore FM, Kanki PJ, Yu QC, Fox JG. Transmission of a chronic lymphoproliferative syndrome in ferrets. Lab Invest. 1995 May; 72(5):539-46.
    View in: PubMed
  87. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994 Sep 9; 265(5178):1587-90.
    View in: PubMed
  88. Kanki PJ, Travers KU, MBoup S, Hsieh CC, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Avila M, Sankalé JL, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 1994 Apr 16; 343(8903):943-6.
    View in: PubMed
  89. Chen YM, Jang YJ, Kanki PJ, Yu QC, Wang JJ, Montali RJ, Samuel KP, Papas TS. Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys. J Virol. 1994 Feb; 68(2):1149-57.
    View in: PubMed
  90. Kane F, Alary M, Ndoye I, Coll AM, M'boup S, Guèye A, Kanki PJ, Joly JR. Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS. 1993 Sep; 7(9):1261-5.
    View in: PubMed
  91. Kashala O, Kayembe K, Kanki P, Mukeba P, Diese M, Kalengayi M, Izzia KW, Essex M. Humoral aspects of anti-HIV immune responses in Zairians with AIDS: lower antigenemia does not correlate with immune complex levels. AIDS Res Hum Retroviruses. 1993 Mar; 9(3):251-8.
    View in: PubMed
  92. Donnelly C, Leisenring W, Kanki P, Awerbuch T, Sandberg S. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull Math Biol. 1993; 55(4):731-43.
    View in: PubMed
  93. Kanki P, M'Boup S, Marlink R, Travers K, Hsieh CC, Gueye A, Boye C, Sankalé JL, Donnelly C, Leisenring W, et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes. Am J Epidemiol. 1992 Oct 1; 136(7):895-907.
    View in: PubMed
  94. Baillou A, Janvier B, Mayer R, Kanki P, M'Boup S, Denis F, Goudeau A, Essex M, Barin F. Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVmac may distinguish subtypes among primate lentiviruses. AIDS Res Hum Retroviruses. 1991 Sep; 7(9):767-71.
    View in: PubMed
  95. M'Boup S, Kanki PJ, Mhalu FS. Laboratory diagnosis of HIV-1 and HIV-2 in Africa. AIDS. 1991; 5 Suppl 1:S93-101.
    View in: PubMed
  96. Kanki PJ. Biologic features of HIV-2. An update. AIDS Clin Rev. 1991; 17-38.
    View in: PubMed
  97. Essex M, Kanki PJ, Marlink R, Chou MJ, Lee TH. Antigenic characterization of the human immunodeficiency viruses. J Am Acad Dermatol. 1990 Jun; 22(6 Pt 2):1206-10.
    View in: PubMed
  98. Zuber M, Samuel KP, Lautenberger JA, Kanki PJ, Papas TS. Bacterially produced HIV-2 env polypeptides specific for distinguishing HIV-2 from HIV-1 infections. AIDS Res Hum Retroviruses. 1990 Apr; 6(4):525-34.
    View in: PubMed
  99. Romieu I, Marlink R, Kanki P, M'Boup S, Essex M. HIV-2 link to AIDS in West Africa. J Acquir Immune Defic Syndr. 1990; 3(3):220-30.
    View in: PubMed
  100. Fincham JE, Van der Riet F, Steytler JG, Tung MT, Cooper R, Seier JV, Madden DL, Kanki P, Campbell JA, Taljaard JJ, et al. Increased peripheral lymphocytes, lymphoid hepatitis and anaemia in African vervet monkeys seropositive to retroviruses. J Comp Pathol. 1989 Jul; 101(1):53-68.
    View in: PubMed
  101. Ayanian JZ, Maguire JH, Marlink RG, Essex M, Kanki PJ. HIV-2 infection in the United States. N Engl J Med. 1989 May 25; 320(21):1422-3.
    View in: PubMed
  102. Kanki PJ. Clinical significance of HIV-2 infection in West Africa. AIDS Clin Rev. 1989; 95-108.
    View in: PubMed
  103. Essex M, Kanki PJ. The origins of the AIDS virus. Sci Am. 1988 Oct; 259(4):64-71.
    View in: PubMed
  104. Hoxie JA, Haggarty BS, Bonser SE, Rackowski JL, Shan H, Kanki PJ. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. J Virol. 1988 Aug; 62(8):2557-68.
    View in: PubMed
  105. Franchini G, Kanki PJ, Bosch ML, Fargnoli K, Wong-Staal F. The simian immunodeficiency virus envelope open reading frame located after the termination codon is expressed in vivo in infected animals. AIDS Res Hum Retroviruses. 1988 Aug; 4(4):251-8.
    View in: PubMed
  106. Kanki PJ, Essex M. Simian T-lymphotropic viruses and related human viruses. Vet Microbiol. 1988 Jul; 17(3):309-14.
    View in: PubMed
  107. Varnier OE, Lillo FB, Schito GC, Lazzarin A, Kanki PJ. Parallel Western blot analysis for HIV-1 and HIV-2 antibodies: absence of HIV-2 infection in Italian subjects at risk for AIDS. AIDS. 1988 Jun; 2(3):215-7.
    View in: PubMed
  108. Marlink RG, Ricard D, M'Boup S, Kanki PJ, Romet-Lemonne JL, N'Doye I, Diop K, Simpson MA, Greco F, Chou MJ, et al. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res Hum Retroviruses. 1988 Apr; 4(2):137-48.
    View in: PubMed
  109. Van der Riet FS, Human PA, Cooper DK, Reichart B, Fincham JE, Kalter SS, Kanki PJ, Essex M, Madden DL, Lai-Tung MT, et al. Virological implications of the use of primates in xenotransplantation. Transplant Proc. 1987 Oct; 19(5):4068-9.
    View in: PubMed
  110. Kanki PJ. West African human retroviruses related to STLV-III. AIDS. 1987 Sep; 1(3):141-5.
    View in: PubMed
  111. Barin F, Denis F, Baillou A, Leonard G, Mounier M, M'Boup S, Gershy-Damet G, Sangare A, Kanki P, Essex M. A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV). J Virol Methods. 1987 Aug; 17(1-2):55-61.
    View in: PubMed
  112. Arya SK, Beaver B, Jagodzinski L, Ensoli B, Kanki PJ, Albert J, Fenyo EM, Biberfeld G, Zagury JF, Laure F, et al. New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature. 1987 Aug 6-12; 328(6130):548-50.
    View in: PubMed
  113. Kanki PJ, M'Boup S, Ricard D, Barin F, Denis F, Boye C, Sangare L, Travers K, Albaum M, Marlink R, et al. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science. 1987 May 15; 236(4803):827-31.
    View in: PubMed
  114. Kanki PJ, Barin F, M'Boup S, Essex M. Relationship of simian T-lymphotropic virus type III to human retroviruses in Africa. Antibiot Chemother. 1987; 38:21-7.
    View in: PubMed
  115. Franchini G, Collalti E, Arya SK, Fenyö EM, Biberfeld G, Zagury JF, Kanki PJ, Wong-Staal F, Gallo RC. Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. AIDS Res Hum Retroviruses. 1987; 3(1):11-7.
    View in: PubMed
  116. Kanki PJ, Hopper JR, Essex M. The origins of HIV-1 and HTLV-4/HIV-2. Ann N Y Acad Sci. 1987; 511:370-5.
    View in: PubMed
  117. Kanki PJ, Allan J, Barin F, Redfield R, Clumeck N, Quinn T, Mowovondi F, Thiry L, Burny A, Zagury D, et al. Absence of antibodies to HIV-2/HTLV-4 in six central African nations. AIDS Res Hum Retroviruses. 1987; 3(3):317-22.
    View in: PubMed
  118. Allan JS, Coligan JE, Lee TH, Barin F, Kanki PJ, M'Boup S, McLane MF, Groopman JE, Essex M. Immunogenic nature of a Pol gene product of HTLV-III/LAV. Blood. 1987 Jan; 69(1):331-3.
    View in: PubMed
  119. Hirsch V, Riedel N, Kornfeld H, Kanki PJ, Essex M, Mullins JI. Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. Proc Natl Acad Sci U S A. 1986 Dec; 83(24):9754-8.
    View in: PubMed
  120. Kanki PJ, Barin F, M'Boup S, Allan JS, Romet-Lemonne JL, Marlink R, McLane MF, Lee TH, Arbeille B, Denis F, et al. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science. 1986 Apr 11; 232(4747):238-43.
    View in: PubMed
  121. Barin F, M'Boup S, Denis F, Kanki P, Allan JS, Lee TH, Essex M. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet. 1985 Dec 21-28; 2(8469-70):1387-9.
    View in: PubMed
  122. Kanki PJ, Alroy J, Essex M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science. 1985 Nov 22; 230(4728):951-4.
    View in: PubMed
  123. Allan JS, Coligan JE, Lee TH, McLane MF, Kanki PJ, Groopman JE, Essex M. A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science. 1985 Nov 15; 230(4727):810-3.
    View in: PubMed
  124. Essex M, Allan J, Kanki P, McLane MF, Malone G, Kitchen L, Lee TH. Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Ann Intern Med. 1985 Nov; 103(5):700-3.
    View in: PubMed
  125. Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Cancer Res. 1985 Sep; 45(9 Suppl):4534s-4538s.
    View in: PubMed
  126. Kanki PJ, Kurth R, Becker W, Dreesman G, McLane MF, Essex M. Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet. 1985 Jun 8; 1(8441):1330-2.
    View in: PubMed
  127. Kanki PJ, McLane MF, King NW, Letvin NL, Hunt RD, Sehgal P, Daniel MD, Desrosiers RC, Essex M. Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science. 1985 Jun 7; 228(4704):1199-201.
    View in: PubMed
  128. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science. 1985 Jun 7; 228(4704):1201-4.
    View in: PubMed
  129. Lee TH, Kanki P, McLane MF, Tachibana N, Essex M. Pathobiology of human T-cell leukemia virus. Prog Clin Biol Res. 1985; 182:213-21.
    View in: PubMed
  130. Kanki PJ, Homma T, Lee TH, King NW, Hunt RD, Essex M. Antibodies to human T-cell leukemia virus-membrane antigens in macaques with malignant lymphoma. Haematol Blood Transfus. 1985; 29:345-9.
    View in: PubMed
  131. Homma T, Kanki PJ, King NW, Hunt RD, O'Connell MJ, Letvin NL, Daniel MD, Desrosiers RC, Yang CS, Essex M. Lymphoma in macaques: association with virus of human T lymphotrophic family. Science. 1984 Aug 17; 225(4663):716-8.
    View in: PubMed
  132. Essex M, Kanki P, Allan J, Barin F, McLane MF, Lee TH, Kitchen L, Homma T, Malone G, Yokota T, et al. HTLV and immunosuppression. Princess Takamatsu Symp. 1984; 15:309-18.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Maria Maxell (mmaxellhsph.harvard.edu).
Kanki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (418) concept(s)
_
Co-Authors
See all (23) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_